Your browser doesn't support javascript.
Prevalence, Distribution and IgG Antibody Levels Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Health-System and Community-Based Employees and Patients.
Kabagambe, Edmond K; Velasco-Gonzalez, Cruz; Henry, Marcia B; Fort, Dan; Wu, Qingli; Sossaman, Gregory; Laborde, Yvens; Price-Haywood, Eboni; Roberts, W Mark; Seoane, Leonardo.
  • Kabagambe EK; Division of Academics, Ochsner Health, New Orleans, LA, USA; Ochsner Center for Outcomes Research, Division of Academics, Ochsner Health, New Orleans, LA, USA. Electronic address: edmond.kabagambe@ochsner.org.
  • Velasco-Gonzalez C; Ochsner Center for Outcomes Research, Division of Academics, Ochsner Health, New Orleans, LA, USA.
  • Henry MB; Division of Academics, Ochsner Health, New Orleans, LA, USA.
  • Fort D; Ochsner Center for Outcomes Research, Division of Academics, Ochsner Health, New Orleans, LA, USA.
  • Wu Q; Department of Pathology, Ochsner Health, New Orleans, LA, USA.
  • Sossaman G; Department of Pathology, Ochsner Health, New Orleans, LA, USA.
  • Laborde Y; Global Health Education, Ochsner Health, New Orleans, LA, USA.
  • Price-Haywood E; Division of Academics, Ochsner Health, New Orleans, LA, USA; Ochsner Center for Outcomes Research, Division of Academics, Ochsner Health, New Orleans, LA, USA; University of Queensland Ochsner Clinical School, Ochsner Health, New Orleans, LA, USA.
  • Roberts WM; Division of Academics, Ochsner Health, New Orleans, LA, USA.
  • Seoane L; Division of Academics, Ochsner Health, New Orleans, LA, USA; University of Queensland Ochsner Clinical School, Ochsner Health, New Orleans, LA, USA.
Am J Med Sci ; 363(1): 18-24, 2022 01.
Article in English | MEDLINE | ID: covidwho-1446372
ABSTRACT

BACKGROUND:

Following the high morbidity and mortality due to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infections in New Orleans, Louisiana, we sought to assess progress toward herd immunity.

METHODS:

Ochsner Health employees and patients who volunteered for Abbott SARS-CoV-2 immunoglobulin G (IgG) antibody test between March 1 and May 1, 2020 were included. We estimated IgG prevalence and used logistic regression to estimate odds ratios (OR) and 95% confidence intervals (CI) for variables associated with IgG test status.

RESULTS:

Of the 13,343 participants with IgG test results, 78.6% were women, 70.6% were non-Hispanic White, 21.1% non-Hispanic Black, 2.9% Hispanic Americans and 5.4% belonged to other races. Overall, 7.99% (95% CI 7.53-8.45%) of the participants tested IgG positive. In age-, sex- and body mass index (BMI)-adjusted analyses, non-Hispanic Blacks were 2.7-times more likely to test positive than non-Hispanic Whites (OR=2.72; 95% CI 2.33-3.19). Corresponding ORs (95% CIs) were 1.29 (0.84-1.99) for Hispanic Americans and 1.22 (0.85-1.75) for Other race/ethnicities. Compared to participants in administrative occupations, physician assistants (OR=7.14; 95% CI 1.72-29.6) and therapists (OR=4.74; 95% CI 1.49-15.03) were significantly more likely to have IgG antibodies while the association among nurses was not significant (OR=2.35; 95% CI 0.96-5.77). Relative to 1.40, the test threshold for positivity, our measurements indicate a strong immune response (5.38±1.69), especially among those with a higher BMI.

CONCLUSIONS:

SARS-COV-2 IgG antibodies were prevalent only in 8% of the participants. IgG prevalence was highest among non-Hispanic Blacks and participants with higher BMI but was lower among older participants.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunoglobulin G / SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Observational study / Prognostic study Limits: Female / Humans / Male Country/Region as subject: North America Language: English Journal: Am J Med Sci Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunoglobulin G / SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Observational study / Prognostic study Limits: Female / Humans / Male Country/Region as subject: North America Language: English Journal: Am J Med Sci Year: 2022 Document Type: Article